TumorTracer 1.1 Server
Go to version 1.0.
TumorTracer was trained to infer the tissue of origin of a tumor, based on somatic mutation and (when available) copy number data.
TumorTracer 1.1 was developed using the COSMIC Whole Genomes database, version 68.
TumorTracer 1.1 differs from version 1.0 only by the user input format; the underlying prediction algorithm is the same.
Currently, TumorTracer covers the following primary sites:
breast, endometrium, kidney, large intestine, liver, lung, ovary, pancreas, prostate and skin.
When copy number aberration data is available, performance of TumorTracer 1.1 is increased, but only the following primary sites are included:
breast, endometrium, kidney, large intestine, lung and ovary.
Marquard AM, Birkbak NJ, Thomas CE, Favero F, Krzystanek M, Lefebvre C, Ferté C, Jamal-Hanjani M, Wilson GA, Shafi S, Swanton C, Andre C, Szallasi Z, Eklund AC.
TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen.
BMC Medical Genomics 2015 Oct 1; 8:58.
Link to journal / PubMed